IRONWOOD PHARMACEUTICALS INC (IRWD)
US46333X1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 92.15M | 656.20M | 620.13M | 362.60M | 177.00M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 129.12M | 115.46M | 114.04M | 122.40M | 117.20M | |||
| Inventories | N/A | N/A | N/A | N/A | 600.00K | |||
| Other Current Assets | 12.01M | 8.96M | 11.05M | 10.90M | 12.00M | |||
| Total Current Assets | 233.29M | 780.63M | 745.23M | 495.80M | 306.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.17M | 20.31M | 22.93M | 25.50M | 30.20M | |||
| Goodwill | N/A | N/A | N/A | N/A | 800.00K | |||
| Intangibles | 3.68M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 215.93M | 284.99M | 334.78M | 14.50M | 32.30M | |||
| Total Non-Current Assets | 237.78M | 319.89M | 381.70M | 63.40M | 95.80M | |||
| TOTAL ASSETS | 471.07M | 1.10B | 1.13B | 559.20M | 402.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 199.56M | 0.00 | 116.86M | N/A | 0.00 | |||
| Accrued Expenses | 67.47M | 25.02M | 42.59M | 31.50M | 34.60M | |||
| Accounts Payable | 7.83M | 483.00K | 935.00K | 700.00K | 5.50M | |||
| Other Current Liabilities | 1.24M | 19.00K | 1.32M | N/A | 900.00K | |||
| Total Current Liabilities | 276.10M | 25.52M | 161.70M | 32.20M | 40.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 498.31M | 396.25M | 337.33M | 430.30M | 408.00M | |||
| Other Non-Current Liabilities | 42.96M | 26.36M | 21.98M | 34.20M | 47.10M | |||
| Total Non-Current Liabilities | 541.27M | 422.62M | 359.32M | 464.40M | 455.10M | |||
| TOTAL LIABILITIES | 817.37M | 448.14M | 521.02M | 496.60M | 496.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.70B | -696.38M | -937.61M | -1.47B | -1.57B | |||
| Additional Paid In Capital | 1.36B | 1.35B | 1.54B | 1.53B | 1.48B | |||
| Minority Interest | 29.32M | N/A | N/A | N/A | N/A | |||
| Common Shares | 156.00K | 154.00K | 162.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | -3.03M | N/A | 605.91M | N/A | N/A | |||
| Shares Outstanding | 156.35M | 154.03M | 162.04M | 160.60M | 157.50M | |||
| Tangible Book Value per Share | -2.24 | 4.24 | 3.74 | 0.39 | -0.60 | |||
| Total Shareholders' Equity | -346.30M | 652.38M | 605.91M | 62.60M | -93.30M | |||
| TOTAL LIABILITIES AND EQUITY | 471.07M | 1.10B | 1.13B | 559.20M | 402.70M | |||
| Statistics | ||||||||
| Debt/Equity | -1.44 | 0.61 | 0.56 | 6.87 | -4.37 | |||
| Current Ratio | 0.84 | 30.58 | 4.61 | 15.40 | 7.50 | |||
| Return On Assets (ROA) | -212.76% | 15.91% | 46.89% | 18.99% | 5.34% | |||
| Return On Equity (ROE) | N/A | 26.83% | 87.22% | 169.65% | N/A | |||
| Return On Invested Capital (ROIC) | 59.88% | 16.15% | 16.68% | 20.60% | 22.29% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 113.55% | 41.46% | 46.65% | 66.02% | 43.65% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 117.77% | 41.46% | 46.65% | 66.02% | 43.84% | |||
All data in USD